COVID-19, glomerulonefritis ANCA y anti-membrana basal glomerular. Caso clínico / Association of COVID-19 and glomerulonephritis with ANCA and anti-glomerular basement membrane antibodies. Report of one case
Rev. med. Chile
;
150(6): 828-831, jun. 2022. ilus
Artículo
en Español
| LILACS
| ID: biblio-1424126
ABSTRACT
Renal involvement in COVID-19 infection is varied and worsens its outcome and prognosis. However, the association of COVID-19 infection with glomerulonephritis is exceptional. We report a 46-year-old woman with COVID-19 who had an acute kidney injury and ANCA associated glomerulonephritis two weeks after the onset of the disease. The kidney biopsy showed a crescentic glomerulo-nephritis and the presence of anti-glomerular basement membrane antibodies (GBM-Abs). She was treated with steroids and oral cyclophosphamide with good response without requiring plasmapheresis. Plasma anti GBM-Abs were negative. This case suggests that the presence of anti-GBM-Abs in the kidney, was temporally related to COVID-19 pulmonary damage. The absence of plasma antibodies is probably due to transient production and glomerular adsorption, but with unknown pathogenic role.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
COVID-19
/
Glomerulonefritis
Límite:
Femenino
/
Humanos
Idioma:
Español
Revista:
Rev. med. Chile
Asunto de la revista:
Medicina
Año:
2022
Tipo del documento:
Artículo
País de afiliación:
Chile
Institución/País de afiliación:
Clínica Indisa/CL
/
Merkén Biotech/CL
Similares
MEDLINE
...
LILACS
LIS